Sponsors
Blog
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?25 May 2011
White Papers
Focus Area: Research & Development
Ushering in the era of personalized healthcare
Next-generation sequencing and genomic enrichment arrays facilitate new research approaches for drug discovery and disease management. By Roche NimbleGen, Inc.
The challenges of biomarkers
The implementation of biomarkers for patient stratification to improve oncology-targeted therapies is still an extremely challenging endeavour with limited success. By Definiens AG
A new model for drug discovery
The productivity crisis in pharmaceutical drug discovery, or ‘innovation gap’ as it has been coined, is well recognised and the subject of much debate in the industry and spectator commentary. By Melior Discovery
Automating life sciences SOPs
Life Sciences organisations often overlook active process compliance as part of process initiatives. By Metastorm
A new PET imaging agent
A new imaging agent, 64Cu-DOTA-bevacizumab, has been developed for scanning of tumor growth and functional imaging of angiogenesis in animal tumor models. By MPI Research
Source: www.ngpharma.eu.com© 2012 GDS Publishing Ltd. All rights reserved.